Clinical evaluation of niflumic acid (Squibb) in rheumatoid arthritis.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000814:Aniline Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D000886:Anthropometry; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007719:Knee Joint; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D010919:Placebos; D011877:Radionuclide Imaging; D013223:Statistics as Topic; D013667:Technetium; D013997:Time Factors; D014955:Wrist Joint
D000700:Analgesics; D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D010919:Placebos; D013667:Technetium